Ophthalmic manifestations of IgG4-related disease: Single-center experience and literature review

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 6, 2014, Pages 806-817

  Wallace, Zachary S ^a   Deshpande, Vikram ^a   Stone, John H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Dacryoadenitis; Idiopathic inflammation; IgG4 related disease; Myositis; Orbital pseudotumor; Rituximab

Indexed keywords

ANTINUCLEAR ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN G4; PREDNISONE; RITUXIMAB; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; BONE DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG RESPONSE; EXOPHTHALMOS; EXTRAOCULAR MUSCLE DISEASE; EYE DISEASE; EYE SWELLING; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; LACRIMAL GLAND DISEASE; MALE; ONSET AGE; PRIORITY JOURNAL; SCLERITIS; SEX RATIO; TREATMENT FAILURE; TRIGEMINAL NERVE DISEASE; VERY ELDERLY; XANTHOGRANULOMA; AUTOIMMUNE DISEASES; COHORT ANALYSIS; COMPLICATION; DACRYOCYSTITIS; EYE DISEASES; IMMUNOLOGY; MIDDLE AGED; ORBITAL MYOSITIS; ORBITAL PSEUDOTUMOR; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOIMMUNE DISEASES; COHORT STUDIES; DACRYOCYSTITIS; EYE DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; ORBITAL MYOSITIS; ORBITAL PSEUDOTUMOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84902537091     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.11.008     Document Type: Article

References (62)

1. Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N Engl J Med 2012, 6:539-551.
2. Carruthers M.N., Stone J.H., Khosroshahi A. The latest on IgG4-RD: a rapidly emerging disease. Curr Opin Rheumatol 2012, 1:60-69.
3. Stone J.H., Khosroshahi A., Deshpande V., Chan J.K., Heathcote J.G., Aalberse R., et al. IgG4-Related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations. Arthritis Rheum 2012, 64:3061-3067.
4. Ferry J., Deshpande V. IgG4-related disease in the head and neck. Semin Diagn Pathol 2012, 29:235-244.
5. Katsura M., Mori H., Kunimatsu A., Sasaki H., Abe O., Machida T., et al. Radiological features of IgG4-related disease in the head, neck, and brain. Neuroradiology 2012, 54:873.
6. Wallace Z.S., Carruthers M.N., Khosroshahi A., Carruthers R., Shinagare S., Stemmer-Rachamimov A., et al. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 2013, 92(4):206-216.
7. Kubota T., Moritani S. Orbital IgG4-related disease: clinical features and diagnosis. ISRN Rheumatol 2012, 412896.
8. Lindfield D., Attfield K., McElvanney A. Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?. Eye 2012, 26:623.
9. Kalapesi F.B., Garrott H.M., Moldovan C., Williams M., Ramanan A., Herbert H.M. IgG4 orbital inflammation in a 5-year-old child presenting as an orbital mass. Orbit 2013, 32:137-140.
10. Plaza J.A., Garrity J.A., Dogan A., Ananthamurthy A., Witzig T.E., Salomão D.R. Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease. Arch Ophthalmol 2011, 129:421.
11. Andrew N., Kearney D., Selva D., Ananthamurthy A., Witzig T.E., Salomão D.R. IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol 2012, [Epub ahead of print].
12. Guma M., Firestein G.S. IgG4-related diseases. Best Pract Res Clin Rheumatol 2012, 26:425-438.
13. Takahira M., Ozawa Y., Kawano M., Zen Y., Hamaoka S., Yamada K., et al. Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. Int J Rheumatol 2012, 635473.
14. Deshpande V., Zen Y., Chan J.K., Yi E.E., Sato Y., Yoshino T., et al. Consensus statement on IgG4-RD diagnosis. Mod Rheumatol 2012, 25:1181-1192.
15. Harrison J., Manuel R.J. Commentary on IgG4-related sialadenitis: Mikulicz's disease, Kuttner's tumour, and eponymy. Histopathology 2011, 58:1164-1166.
16. Yamamoto M., Takahashi H., Ohara M., Suzuki C., Naishiro Y., Yamamoto H., et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006, 16:335-340.
17. Karamchandani J.R., Younes S.F., Warnke R.A., Natkunam Y. IgG4-related systemic sclerosing disease of the ocular adnexa: a potential mimic of ocular lymphoma. Am J Clin Pathol 2012, 137:699.
18. Higashiyama T., Nishida Y., Ugi S., Ishida M., Nishio Y., Ohji M. A case of extraocular muscle swelling due to IgG4-related sclerosing disease. Jpn J Ophthalmol 2011, 55:315.
19. Morel N., Rigolet A., Schleinitz N., Garnier A., Costedoat-Chalumeau N. Bilateral enlargement of the lacrimal glands from IgG4-related systemic disease. Ann Intern Med 2012, 156:669.
20. Wallace Z.S., Khosroshahi A., Jakobiec F.A., Deshpande V., Hatton M.P., Ritter J., et al. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 2012, 1:26-33.
21. Costa R.M., Dumitrascu O.M., Gordon L.K. Orbital myositis: diagnosis and management. Curr Allergy Asthma Rep 2009, 9:316-323.
22. Espinoza G.M. Orbital inflammatory pseudotumors: etiology, differential diagnosis, and management. Curr Rheumatol Rep 2010, 12:443-447.
23. Suzuki M., Mizumachi T., Morita S., Kubota K., Iizuka K. A case of immunoglobulin 4-related disease with bilateral mass-forming lesions in the nasolacrimal ducts. J Clin Rheumatol 2011, 17:207.
24. Altan-Yaycioglu R., Canan H., Sizmaz S., Bal N., Pelit A., Akova Y. Nasolacrimal duct obstruction: clinicopathologic analysis of 205 cases. Orbit 2010, 29:254-258.
25. Lee-Wing M.W., Ashenhurst M.E. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction. Ophthalmology 2001, 108:2038-2040.
26. Kosakai A., Ito D., Yamada S., Ideta S., Ota Y., Suzuki N. A case of definite IgG4-related pachymeningitis. Neurology 2010, 15:1390-1392.
27. Galor A., Thorne J. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am 2007, 33:835-854.
28. Sivak-Callcott J.A., Rootman J., Rasmussen S.L., Nugent R.A., White V.A., Paridaens D., et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol 2006, 90:602-608.
29. Mudhar H., Bhatt R., Sandramouli S. Xanthogranulomatous variant of immunoglobulin G4 sclerosing disease presenting as ptosis, proptosis and eyelid skin plaques. Int Ophthalmol 2011, 31:245-248.
30. Roggin K.K., Rudloff U., Klimstra D.S., Russell L.A., Blumgart L.H. Adult-onset asthma and periocular xanthogranulomas in a patient with lymphoplasmacytic sclerosing pancreatitis. Pancreas 2007, 34:157-160.
31. Singh K., Rajan K.D., Eberhart C. Orbital necrobiotic xanthogranuloma associated with systemic IgG4 disease. Ocul Immunol Inflamm 2010, 18:373-378.
32. Strehl J.D., Hartman A., Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol 2011, 64:e237-e243.
33. Alt J., Whitaker G., Allan R., Vaysberg M. Locally destructive skull base lesion: IgG4-related sclerosing disease. Allergy Rhinol 2012, 3:e41-e45.
34. Ishida M., Hotta M., Kushima R., Shibayama M., Shimizu T., Okabe H. Multiple IgG4-related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum. Pathol Int 2009, 59:670-675.
35. Masterson L., Martinez del Pero M., Donnelly N., Moffat D., Rytina E. Immunoglobulin G4 related systemic sclerosing disease involving the temporal bone. J Laryngol Otol 2010, 124:1106-1110.
36. Ono K., Shiiba M., Yoshizaki M., Ogawara K., Ishihara T., Yonemori Y., et al. Immunoglobulin G4-related sclerosing inflammatory pseudotumors presenting in the oral cavity. J Oral Maxillofac Surg 2012, 70:1593-1598.
37. Schiffenbauer A.I., Gahl W.A., Jaffe E., Wahl C., Khosroshahi A., Deshpande V., et al. IgG4-related disease masquerading as recurrent mastoiditis. Laryngologist 2012, 122(3):681-684. [Epub 2012 Jan 17]. 10.1002/lary.22486.
38. Katsura M., Morita A., Horiuchi H., Ohtomo K., Machida T. IgG4-related inflammatory pseudotumor of the trigeminal nerve: another component of IgG4-related sclerosing disease?. Am J Neuroradiol 2011, 32:E150-E152.
39. Garg V., Temin N., Hildenbrand P., Silverman M., Catalano P. Inflammatory pseudotumor of the skull base. Otolaryngol Head Neck Surg 2010, 142:129.
40. Strasnick B., Vaughan A. Inflammatory pseudotumor of the temporal bone: a case series. Skull Base 2008, 18:49-52.
41. Williamson R., Paueksakon P., Coker N. Inflammatory pseudotumor of the temporal bone. Otol Neurotol 2003, 24:818-822.
42. Inoue D., Zen Y., Sato Y., Abo H., Demachi H., Uchiyama A., et al. IgG4-related perinerual disease. Int J Rheumatol 2012, 2012:401890. [Epub 2012 Jan 18]. 10.1155/2012/401890.
43. Ohshima K., Sogabe Y., Sato Y. The usefulness of infraorbital nerve enlargement on MRI in clinical diagnosis of IgG4-related orbital disease. Jpn J Ophthalmol 2012, 56:380.
44. Sogabe Y., Miyatani K., Goto R., Ishii G., Ohshima K., Sato Y. Pathological findings of infraorbital nerve enlargement in IgG4-related ophthalmic disease. Jpn J Ophthalmol 2012, 56:511.
45. Lutt J.R., Lim L.L., Phal P.M., Rosenbaum J.T. Orbital inflammatory disease. Semin Arthritis Rheum 2008, 37:207-222.
46. Colnaghi S, Versino M, Marchioni E, Pichiecchio A, Bastianello S, Cosi V, et al. ICHD-II diagnostic criteria for Tolosa-Hunt syndrome in idiopathic inflammatory syndromes of the orbit and/or the cavernous sinus. Cephalagi.
47. Umehara H., Kazuichi O., Masaki Y., Kawano M., Yamamoto M., Saeki T., et al. Comprehensive diagnostic criteria for IgG4-related disease, 2011. Mod Rheumatol 2012, 22:21.
48. Song Y.S., Choung H.K., Park S.W., Kim J.H., Khwarg S.I., Jeon Y.K. Ocular adnexal IgG4-related disease: CT and MRI findings. Br J Ophthalmol 2013, 97:412-418.
49. Nakatani K., Nakamoto Y., Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol 2012, 67:297.
50. Yamamoto M., Tabeya T., Naishiro Y., Yajima H., Ishigami K., Shimizu Y., et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic disease and other diseases. Mod Rheumatol 2012, 22:419.
51. Ebbo M., Daniel L., Pavic M., Sève P., Hamidou M., Andres E., et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) 2012, 91:49-56.
52. Pakrou N., Selva D., Leibovitch I. Wegener's granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum 2006, 35:284.
53. Chang S.Y., Keogh K., Lewis J., Ryu J., Yi E. Increased IgG4-positive plasma cells in granulomatosis with polyangiitis: a diagnostic pitfall of IgG4-related disease. Int J Rheumatol 2012, 121702.
54. Demirci H., Christianson M.D. Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases. Am J Ophthalmol 2011, 151:1074-1080.
55. Mavrikakis I., Rootman J. Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol 2007, 144:769.
56. Prabhakaran V.C., Saeed P., Esmaeli B., Sullivan T.J., McNab A., Davis G., et al. Orbital and adnexal sarcoidosis. Arch Ophthalmol 2007, 125:1657-1662.
57. Stefanovic A., Lossos I. Extranodal marginal zone lymphoma of the ocular adnexa. Blood 2009, 114:501-510.
58. McKelvie P.A. Ocular adnexal lymphomas: a review. Adv Anat Pathol 2010, 17:251-261.
59. Khosroshahi A., Stone J.H. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 2011, 23:67-71.
60. Hart P.A., Kamisawa T., Brugge W.R., Chung J.B., Culver E.L., Czakó L., et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2012.
61. Khosroshahi A., Carruthers M.N., Deshpande V., Unizony S., Bloch D.B., Stone J.H. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 2012, 91:57-66.
62. Shimizu Y., Yamamoto M., Naishiro Y., Sudoh G., Ishigami K., Yajima H., et al. Necessity of early intervention for IgG4-related disease-delayed treatment induces fibrosis progression. Rheumatology (Oxford) 2013, 52:679-683.